Evidence map›Paper›PMID 25471374›Full record

ArticleThe Journal of biological chemistry2015

Mechanisms of human erythrocytic bioactivation of nitrite.

Chen Liu, Nadeem Wajih, Xiaohua Liu, Swati Basu, John Janes, Madison Marvel, Christian Keggi, Christine C Helms, Amber N Lee, Andrea M Belanger and 6 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Hemoglobin as an oxygen gasoreceptor.Acta biochimica Polonica · 2025
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Chen LiuFrom the Department of Physics and.
Nadeem WajihFrom the Department of Physics and.
Xiaohua LiuFrom the Department of Physics and.
Swati BasuFrom the Department of Physics and the Translational Science Center Wake Forest University, Winston-Salem, North Carolina 27109, the Departments of Radiology and.
John JanesFrom the Department of Physics and.
Madison MarvelFrom the Department of Physics and.
Christian KeggiFrom the Department of Physics and.
Christine C HelmsPhysics Department, University of Richmond, Richmond, Virgina 23173.
Amber N LeeFrom the Department of Physics and.
Andrea M BelangerFrom the Department of Physics and.
Debra I Dizthe Translational Science Center Wake Forest University, Winston-Salem, North Carolina 27109, Hypertension and Vascular Research Center and.
Paul J Laurientithe Translational Science Center Wake Forest University, Winston-Salem, North Carolina 27109, the Departments of Radiology and Biomedical Engineering and.
David L CaudellPathology-Comparative Medicine, Wake Forest University School of Medicine, Winston-Salem, North Carolina 27157, and.
Jun WangHeart, Lung, Blood, and Vascular Medicine Institute and.
Mark T GladwinHeart, Lung, Blood, and Vascular Medicine Institute and the Department of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213.
Daniel B Kim-ShapiroFrom the Department of Physics and the Translational Science Center Wake Forest University, Winston-Salem, North Carolina 27109, Hypertension and Vascular Research Center and Biomedical Engineering and shapiro@wfu.edu.
Winston-Salem/Forsyth County Schools · USWake Forest University · USUniversity of Pittsburgh · USUniversity of Richmond · US

Funding

Tumor Tissue CoreP30CA012197 · NCI · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Ruben A. Mesa · 1985 to 2026
$55.4M
Storage Lesion in Banked Blood Due to Disruption of Nitric Oxide HomeostasisR01HL098032 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Mark T Gladwin · 2009 to 2026
$12.5M
Effects of Nitric Oxide in Sickle Cell BloodR37HL058091 · NHLBI · WAKE FOREST UNIVERSITY · PI KIM-SHAPIRO, DANIEL B · 2007 to 2016
$3.5M
Effects of Nitric Oxide in Sickle Cell BloodR01HL058091 · NHLBI · WAKE FOREST UNIVERSITY · PI KIM-SHAPIRO, DANIEL B · 2002 to 2006
$1.6M
Function and regulation of SirT1 in cancerR01CA121291 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI CHEN, JIANDONG · 2007 to 2011
$1.4M
MECHANISM AND KINETICS OF SICKLE CELL HEMOGLOBINR29HL058091 · NHLBI · WAKE FOREST UNIVERSITY · PI KIM-SHAPIRO, DANIEL B · 1998 to 2002
$260k
NCI NIH HHS P30 CA012197NCI NIH HHS P30 CA121291-37NCI NIH HHS R01 CA121291NHLBI NIH HHS HL058091NHLBI NIH HHS HL098032NHLBI NIH HHS R01 HL058091NHLBI NIH HHS R01 HL098032NHLBI NIH HHS R29 HL058091NHLBI NIH HHS R37 HL058091
6 · The paper itself

Abstract

Nitrite signaling likely occurs through its reduction to nitric oxide (NO). Several reports support a role of erythrocytes and hemoglobin in nitrite reduction, but this remains controversial, and alternative reductive pathways have been proposed. In this work we determined whether the primary human erythrocytic nitrite reductase is hemoglobin as opposed to other erythrocytic proteins that have been suggested to be the major source of nitrite reduction. We employed several different assays to determine NO production from nitrite in erythrocytes including electron paramagnetic resonance detection of nitrosyl hemoglobin, chemiluminescent detection of NO, and inhibition of platelet activation and aggregation. Our studies show that NO is formed by red blood cells and inhibits platelet activation. Nitric oxide formation and signaling can be recapitulated with isolated deoxyhemoglobin. Importantly, there is limited NO production from erythrocytic xanthine oxidoreductase and nitric-oxide synthase. Under certain conditions we find dorzolamide (an inhibitor of carbonic anhydrase) results in diminished nitrite bioactivation, but the role of carbonic anhydrase is abrogated when physiological concentrations of CO2 are present. Importantly, carbon monoxide, which inhibits hemoglobin function as a nitrite reductase, abolishes nitrite bioactivation. Overall our data suggest that deoxyhemoglobin is the primary erythrocytic nitrite reductase operating under physiological conditions and accounts for nitrite-mediated NO signaling in blood.

Indexed as

Oxidation-ReductionBlood PlateletsCarbonic AnhydrasesElectron Spin Resonance SpectroscopyErythrocytesHemoglobinsHumansNitric OxideNitrite ReductasesNitritesSignal TransductionSulfonamidesThiophenesCarbonic AnhydrasesdorzolamideHemoglobinsNitric OxideNitrite ReductasesNitritesnitrosyl hemoglobinSulfonamidesThiophenesErythrocyteHemoglobinNitric OxideNitritePlateletRedox SignalingSpectroscopy

Identifiers

PMID25471374
PMCPMC4294492
OpenAlexW2012574454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.